Position in RPRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$15,533,789
+$3,359,330 QoQ
Shares Held
323,823
+2.8% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AVIVA PLC holds $267,602,543 across 25 Biotechnology names. RPRX ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
222,452 | $99,333,716 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
91,176 | $70,446,224 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
114,003 | $37,720,172 | |
| 4 | INSM |
INSMED Inc
|
122,074 | $19,961,540 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
323,823 | $15,533,789 | |
| 6 | INCY |
Incyte Corp
|
148,088 | $13,938,042 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
21,460 | $2,086,985 | |
| 8 | EXEL |
Exelixis, Inc.
|
25,153 | $1,078,812 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,533,789 | 323,823 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $12,174,459 | 315,074 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $10,525,188 | 298,333 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,109,261 | 280,579 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $8,193,478 | 263,202 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,843,550 | 229,069 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $399,539 | 14,123 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $373,689 | 14,171 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $430,373 | 14,171 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $393,091 | 13,994 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $379,797 | 13,994 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $431,804 | 14,047 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $685,650 | 19,030 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,974,774 | 49,969 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,049,863 | 51,017 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,158,297 | 75,126 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $3,247,277 | 83,349 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,010,631 | 50,455 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $2,002,408 | 55,407 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,258,000 | 103,879 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $4,463,154 | 102,319 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,694,192 | 33,850 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||